Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_assertion description "[The MEF2A mutations may account for up to 1.93% of the disease population; thus, genetic testing based on mutational analysis of MEF2A may soon be available for many coronary artery disease/myocardial infarction patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_assertion evidence source_evidence_literature NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_assertion SIO_000772 15861005 NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_assertion wasDerivedFrom befree-20140225 NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_assertion wasGeneratedBy ECO_0000203 NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP404063.RAVGemhZT6IhKbAOkFxrC9OVU5ZQlqgB7F7OP3Xntl1GM130_provenance.